Philip Gould
London
Founder, OVO Manufacturing

About

Our business centres on the identification of a naturally occurring biological contaminant that significantly reduces viral vaccine yields (up to 1000-fold).

We have developed a technology platform that can identify and reduce the impact of this contaminant leading to significant improvements in yields and profits without impacting regulatory compliance.

Matchmaking Information

Loading...
Processing. Please wait.
Loading...